Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
The New England Journal of Medicine|June 10, 1976
Huntington's chorea. Changes in neurotransmitter receptors in the brainS J Enna, E D Bird, J P Bennett, et al.Experimental Neurology|March 16, 2000
Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell linesP A Trimmer, R H Swerdlow, J K Parks, et al.Neurology|October 27, 1997
Cybrids in Alzheimer's disease: a cellular model of the disease?R H Swerdlow, J K Parks, D S Cassarino, et al.Experimental Neurology|May 19, 2001
Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjectsR H Swerdlow, J K Parks, D S Cassarino, et al.Biochimica Et Biophysica Acta|January 20, 1998
Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's diseaseD S Cassarino, C P Fall, R H Swerdlow, et al.Annals of Neurology|October 1, 1996
Origin and functional consequences of the complex I defect in Parkinson's diseaseR H Swerdlow, J K Parks, S W Miller, et al.Journal of Neurochemistry|September 15, 2000
Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsyR H Swerdlow, L I Golbe, J K Parks, et al.Annals of Neurology|December 16, 1998
Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease familyR H Swerdlow, J K Parks, J N Davis, et al.Annals of Neurology|August 12, 2000
Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathwaysS M Khan, D S Cassarino, N N Abramova, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled studyJ T Hutton, L V Metman, T N Chase, et al.Pageof 17